These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 35021334

  • 21. Fixed-ratio discrimination training as replacement therapy in Parkinson's disease: studies in a 6-hydroxydopamine-treated rat model.
    Van Keuren KR, Stodgell CJ, Schroeder SR, Tessel RE.
    Brain Res; 1998 Jan 05; 780(1):56-66. PubMed ID: 9473587
    [Abstract] [Full Text] [Related]

  • 22. Distinct temporal spike and local field potential activities in the thalamic parafascicular nucleus of parkinsonian rats during rest and limb movement.
    Wang M, Qu Q, He T, Li M, Song Z, Chen F, Zhang X, Xie J, Geng X, Yang M, Wang X, Lei C, Hou Y.
    Neuroscience; 2016 Aug 25; 330():57-71. PubMed ID: 27238892
    [Abstract] [Full Text] [Related]

  • 23. Additional noradrenergic depletion aggravates forelimb akinesia and abnormal subthalamic nucleus activity in a rat model of Parkinson's disease.
    Wang Y, Chen X, Wang T, Sun YN, Han LN, Li LB, Zhang L, Wu ZH, Huang C, Liu J.
    Life Sci; 2014 Dec 05; 119(1-2):18-27. PubMed ID: 25445222
    [Abstract] [Full Text] [Related]

  • 24. Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions.
    Chen L, Liu J, Ali U, Gui ZH, Hou C, Fan LL, Wang Y, Wang T.
    Brain Res Bull; 2011 Feb 28; 84(3):215-23. PubMed ID: 21255635
    [Abstract] [Full Text] [Related]

  • 25. Place conditioning to apomorphine in rat models of Parkinson's disease: differences by dose and side-effect expression.
    Campbell JC, Jeyamohan SB, De La Cruz P, Chen N, Shin D, Pilitsis JG.
    Behav Brain Res; 2014 Dec 15; 275():114-9. PubMed ID: 25205367
    [Abstract] [Full Text] [Related]

  • 26. Activation of dopamine cell firing by repeated L-DOPA administration to dopamine-depleted rats: its potential role in mediating the therapeutic response to L-DOPA treatment.
    Harden DG, Grace AA.
    J Neurosci; 1995 Sep 15; 15(9):6157-66. PubMed ID: 7666198
    [Abstract] [Full Text] [Related]

  • 27. Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol.
    Xu D, Karain B, Brantley E, Shi WX.
    J Pharmacol Exp Ther; 2011 May 15; 337(2):533-9. PubMed ID: 21330359
    [Abstract] [Full Text] [Related]

  • 28. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
    Yuan H, Sarre S, Ebinger G, Michotte Y.
    Brain Res; 2004 Nov 05; 1026(1):95-107. PubMed ID: 15476701
    [Abstract] [Full Text] [Related]

  • 29. The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: A comparative study of lactacystin and 6-OHDA.
    Konieczny J, Czarnecka A, Lenda T, Kamińska K, Antkiewicz-Michaluk L.
    Neuroscience; 2017 Jan 06; 340():308-318. PubMed ID: 27826109
    [Abstract] [Full Text] [Related]

  • 30. Changes in the firing activity of serotonergic neurons in the dorsal raphe nucleus in a rat model of Parkinson's disease.
    Zhang QJ, Gao R, Liu J, Liu YP, Wang S.
    Sheng Li Xue Bao; 2007 Apr 25; 59(2):183-9. PubMed ID: 17437041
    [Abstract] [Full Text] [Related]

  • 31. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L, Wang H, Ba YY, Liu HL, Wang M, Guo WW, Wu X, Yang H.
    Zhongguo Zhong Yao Za Zhi; 2014 May 25; 39(9):1660-5. PubMed ID: 25095380
    [Abstract] [Full Text] [Related]

  • 32. Highly sensitive detection of quantal dopamine secretion from pheochromocytoma cells using neural microelectrode array electrodeposited with polypyrrole graphene.
    Wang L, Xu H, Song Y, Luo J, Wei W, Xu S, Cai X.
    ACS Appl Mater Interfaces; 2015 Apr 15; 7(14):7619-26. PubMed ID: 25804204
    [Abstract] [Full Text] [Related]

  • 33. Activation of 5-HT₁A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease.
    Sun YN, Wang T, Wang Y, Han LN, Li LB, Zhang YM, Liu J.
    Neuropharmacology; 2015 Aug 15; 95():181-91. PubMed ID: 25797491
    [Abstract] [Full Text] [Related]

  • 34. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H, Jia L, Chen X, Shi L, Xie J.
    Brain Res Bull; 2018 Mar 15; 137():132-139. PubMed ID: 29174294
    [Abstract] [Full Text] [Related]

  • 35. Research on the Characteristics of Action Potentials and Local Field Potentials in Cortex of Parkinson's Disease Mode Monkey.
    Xu S, Zhang Y, Xiao G, Duan Y, Wang M, Song Y, Dai Y, Liu J, Luo J, Zhang S, Zhuang P, Chan P, Yue F, Cai X.
    Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul 15; 2020():880-883. PubMed ID: 33018125
    [Abstract] [Full Text] [Related]

  • 36. Histaminergic activity in a rodent model of Parkinson's disease.
    Nowak P, Noras L, Jochem J, Szkilnik R, Brus H, Körossy E, Drab J, Kostrzewa RM, Brus R.
    Neurotox Res; 2009 Apr 15; 15(3):246-51. PubMed ID: 19384597
    [Abstract] [Full Text] [Related]

  • 37. State-Dependent Spike and Local Field Synchronization between the Thalamic Parafascicular Nucleus and the Dorsal Striatum in a Rat Model of Parkinson's Disease.
    Zhang H, Yang J, Xiang T, Sun S, Wang X, Wang X, Li M, Guo M, Jia Q, Chen D, Wang M.
    Neuroscience; 2019 Apr 15; 404():27-38. PubMed ID: 30790668
    [Abstract] [Full Text] [Related]

  • 38. High-frequency stimulation of the subthalamic nucleus restores neural and behavioral functions during reaction time task in a rat model of Parkinson's disease.
    Li XH, Wang JY, Gao G, Chang JY, Woodward DJ, Luo F.
    J Neurosci Res; 2010 May 15; 88(7):1510-21. PubMed ID: 20025062
    [Abstract] [Full Text] [Related]

  • 39. L-DOPA-elicited abnormal involuntary movements in the rats damaged severely in substantia nigra by 6-hydroxydopamine.
    Wang R, Shao M.
    Ann Palliat Med; 2020 May 15; 9(3):947-956. PubMed ID: 32279520
    [Abstract] [Full Text] [Related]

  • 40. Is nicotine protective against Parkinson's disease? An experimental analysis.
    García-Montes JR, Boronat-García A, López-Colomé AM, Bargas J, Guerra-Crespo M, Drucker-Colín R.
    CNS Neurol Disord Drug Targets; 2012 Nov 01; 11(7):897-906. PubMed ID: 23131151
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.